Ashwagandha Dosage Calculator

What is Ashwagandha?

Ashwagandha (Withania somnifera, family Solanaceae) is a small, perennial shrub native to India, North Africa, and the Mediterranean. Its root has been central to Ayurvedic medicine for over 3,000 years under the Sanskrit designation "Rasayana" — a category of herbs believed to promote longevity, vitality, and cognitive function. Modern pharmacology has identified the primary active compounds as steroidal lactones called withanolides (particularly withaferin A, withanolide D, and withanolide A), alongside alkaloids, saponins, and iron. **Mechanism — the HPA axis:** Ashwagandha's most clinically substantiated action is modulation of the hypothalamic-pituitary-adrenal (HPA) axis, the hormonal cascade governing the stress response. Under chronic stress, the HPA axis produces excessive cortisol, contributing to anxiety, disrupted sleep, immune suppression, and muscle catabolism. Withanolides appear to downregulate cortisol secretion through actions on both corticotropin-releasing factor (CRF) receptors in the hypothalamus and adrenocortical tissue directly. A 2019 randomised, double-blind, placebo-controlled trial (Langade et al., Cureus, PMID 31728244) demonstrated a 14.5% reduction in serum cortisol and a 72-point improvement on insomnia severity index (ISI) with 300 mg KSM-66 twice daily. **Testosterone and male reproductive health:** At least six RCTs have examined the effect of ashwagandha on testosterone. A 2019 prospective study in overweight males (Lopresti et al., American Journal of Men's Health) found 8 weeks of KSM-66 at 600 mg/day increased testosterone by 14.7% and DHEA-S by 18%, compared to no significant change in placebo. A 2010 study in infertile men found a 17% increase in testosterone alongside improvements in sperm count and motility. The mechanism likely involves dual action: cortisol reduction (cortisol inhibits Leydig cell testosterone synthesis) and direct stimulatory effects on the hypothalamic-pituitary-gonadal (HPG) axis. **Cognitive function:** Ashwagandha's withanolides promote axonal and dendritic growth in neurite outgrowth assays and upregulate BDNF (brain-derived neurotrophic factor) in animal models. A 2017 RCT (Choudhary et al., Journal of Dietary Supplements) confirmed improvements in immediate and general memory, executive function, and information processing speed in adults with mild cognitive impairment supplementing with 300 mg KSM-66 twice daily for 8 weeks. **Extract standardisation:** The clinical evidence base is concentrated on two patented extracts — KSM-66 (full-spectrum root extract, standardised to ≥5% withanolides, manufactured by Ixoreal Biomed) and Sensoril (root-and-leaf aqueous extract, standardised to ≥10% withanolides, by Natreon Inc.). Both have been used in multiple Phase II-equivalent RCTs. Generic "ashwagandha root powder" at equivalent gram doses contains highly variable withanolide concentrations and should not be assumed equivalent.

How to Take Ashwagandha

The clinically validated dose range is 300–600 mg per day of a standardised root extract (KSM-66 or Sensoril). Most published trials use 300 mg taken twice daily (600 mg total), which is the dose associated with the strongest cortisol-lowering and testosterone-supporting effects. For sleep-focused use, 300 mg at bedtime has been studied with positive outcomes. **Choosing between KSM-66 and Sensoril:** - **KSM-66** is the most widely studied form, uses only root material (traditional Ayurvedic practice), and has the most RCT evidence for stress, testosterone, and athletic performance. Dose: 300–600 mg/day. - **Sensoril** uses both root and leaf extract, achieving higher withanolide concentration (≥10% vs ≥5%), meaning it may be effective at lower doses (125–250 mg/day). Best evidence is for stress and anxiety reduction. **Onset timeline:** Unlike anxiolytics that produce acute effects, ashwagandha's benefits accumulate over 4–12 weeks of consistent use. Cortisol and sleep improvements typically manifest by week 4–6; testosterone changes by week 8–12. Do not discontinue prematurely based on lack of acute effect. **Cycling protocol:** While evidence for tolerance development is absent, a conservative cycling approach of 8–12 weeks supplementation followed by a 4-week washout is standard practice in integrative medicine to prevent HPA axis accommodation. Cycling is especially prudent when using doses at the upper range (600 mg/day). **With or without food:** Taking ashwagandha with food significantly reduces the incidence of GI discomfort. The bioavailability difference between fed and fasted states is minor for standardised extracts.

Timing Recommendations

Timing can be strategically optimised based on your primary goal. **For stress and cortisol reduction:** Split the daily dose in two — one serving in the morning with breakfast (to blunt the cortisol awakening response, which peaks 30–45 minutes after waking), and one in the evening with dinner. This matches the circadian pattern of cortisol secretion and provides continuous HPA axis modulation across the day's highest-stress periods. **For sleep improvement:** A single dose of 300–600 mg taken 30–60 minutes before bed is the evidence-supported protocol. The Langade et al. 2019 trial specifically showed improvements in sleep quality, sleep latency, and morning wakefulness with this timing. The glycine-like inhibitory properties of some withanolide metabolites may contribute to the GABAergic calming effect. **For testosterone and athletic performance:** Post-workout supplementation (alongside a meal) has been used in several sports performance studies. The cortisol-blunting effect post-exercise reduces catabolic signalling and may protect muscle protein synthesis. Alternatively, morning and post-workout split dosing covers both the circadian cortisol peak and exercise-induced cortisol spikes.

Potential Side Effects & Safety

Ashwagandha is well-tolerated in the majority of individuals at clinical doses (300–600 mg/day) for periods up to 12 weeks as studied in RCTs. The most common adverse effects are mild and GI-related: nausea, loose stools, and stomach upset, occurring in approximately 5–10% of users and generally resolving with food co-administration or dose reduction. **Hepatotoxicity — a rare but real concern:** As of 2023, the European Pharmacopoeia Database and several pharmacovigilance systems have catalogued approximately 30 cases of drug-induced liver injury (DILI) potentially associated with ashwagandha products. Most cases resolved completely on discontinuation, with rare cases requiring medical management. The causative withanolide(s) remain unidentified, and several cases involved adulterated or contaminated products. The absolute risk is very low, but users should be aware and discontinue immediately if symptoms of liver dysfunction appear (jaundice, right-upper-quadrant pain, dark urine, fatigue). **Sedation:** Ashwagandha can potentiate the sedative effects of benzodiazepines, barbiturates, and other CNS depressants. Exercise caution if taking sleep medications or anxiolytics concurrently. **Thyroid hormones:** Multiple trials report modest increases in T3 and T4 levels with ashwagandha supplementation, which is beneficial for hypothyroid individuals but requires dose adjustment monitoring in those on levothyroxine or other thyroid medications.

Best Stacks with Ashwagandha

Ashwagandha + magnesium glycinate (200–400 mg) is one of the most popular evidence-aligned sleep stacks, with each compound acting on complementary pathways (HPA axis modulation vs. NMDA antagonism and GABAergic facilitation). Ashwagandha + L-theanine (200 mg, a green tea amino acid) creates a daytime stress-management stack without sedation. For male hormonal health, combining ashwagandha with zinc (30 mg/day) and vitamin D3 (2,000 IU/day) addresses multiple testosterone co-factors simultaneously. Some sports nutrition formulators combine ashwagandha with rhodiola rosea (another adaptogen) for a broader HPA + sympathoadrenal axis modulation effect, though head-to-head combination trials are limited.

Scientific References

All dosage recommendations are grounded in peer-reviewed research.

1. 1
   Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study

   Cureus · 2019

2. 2
   A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males

   American Journal of Men's Health · 2019

3. 3
   Improvements in brain function and working memory following a randomized, double-blind, placebo-controlled study with ashwagandha (KSM-66)

   Journal of Dietary Supplements · 2017

4. 4
   An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract

   Medicine · 2019